【Award】Our research and development has been awarded the 2024 Catalyst Phase of the Healthy Longevity Global Competition (NAM-HLGC), an initiative of the US National Academy of Medicine (NAM).

The NAM-HLGC is a three-phase grant program that encourages innovation and scientific advances and breakthroughs that extend healthy life expectancy. The first phase, “Catalyst Phase,” is for new ideas that will contribute to extending healthy life expectancy. Our research was awarded 2024 Catalyst Phase.

https://healthylongevitychallenge.org/winners/development-of-a-hybrid-nano-coated-nitinol-drug-eluting-stent-hybrid-des-for-small-atherosclerotic-lesions-in-below-the-knee-btk/